Pharmaceutical Intermediate CAS 33818-15-4 USP Standar API Citicoline Sodium Powder for Nootropic Drugs

China Pharmaceutical Intermediate CAS 33818-15-4 USP Standar API Citicoline Sodium Powder for Nootropic Drugs, Find details about China Citicoline Sodium, Citicoline Sodium Powder from Pharmaceutical Intermediate CAS 33818-15-4 USP Standar API Citicoline Sodium Powder for Nootropic Drugs

Model NO.
E-345
Name
Citicoline Sodium
CAS
33818-15-4
Molecular Formula
C14h25n4nao11p2
Molecular Weight
510.31
Appearance
White Powder
Package
1kg/Bag
Trademark
GREENWAY
Transport Package
1kg/Bag; 25kg/Carton
Specification
99%
Origin
Jiangsu, China
HS Code
2942000000
Model NO.
E-345
Name
Citicoline Sodium
CAS
33818-15-4
Molecular Formula
C14h25n4nao11p2
Molecular Weight
510.31
Appearance
White Powder
Package
1kg/Bag
Trademark
GREENWAY
Transport Package
1kg/Bag; 25kg/Carton
Specification
99%
Origin
Jiangsu, China
HS Code
2942000000
Pharmaceutical Intermediate CAS 33818-15-4 USP Standar API Citicoline Sodium Powder For Nootropic Drugs
Pharmaceutical Intermediate CAS 33818-15-4 USP Standar API Citicoline Sodium Powder for Nootropic Drugs
Product NameCiticoline sodium
CAS NO.33818-15-4
Other NameP'-[2-(TRIMETHYLAMMONIO)ETHYL]ESTERCYTIDINE5'-(TRIHYDROGENDIPHOSPHATE)INNERSALTMONOSODIUM;cytidine5'-(trihydrogendiphosphate)p'-[2-(trimethylammonio)ethyl]esterinnersaltmonosodiumsalt;CYTIDINE-5'-DIPHChemicalbookOSPHOCHOLINEMONOSODIUMSALT;CYTIDINE-5'-DIPHOSPHOCHOLINE,NA;CYTIDINE-5'-DIPHOSPHOCHOLINE,SODIUM;CYTIDINE5'-DIPHOSPHOCHOLINESODIUMSALT;CYTIDINE5'-DIPHOSPHOCHOLINESODIUMSALTDIHYDRATE;CITICOLINESODIUMSALT
Molecular FormularC14H25N4NaO11P2
Molecular Weight510.31
AppearanceWhite powder
BrandGreenway
Purity99%
ApplicationPharmaceutical Intermediates
Melting Point259-268°C

Citicoline sodium is the sodium form of citicoline, More stable in nature and better in price.
CDPC is a coenzyme.It is a ramification of nucleotide and the main coenzyme of composing lecithin. It can advance the cell metabolism,
improving the brain fumction and brain system reticular structure activation system, etc. In clinical application, CDPC can bi used to cure
acute craniocerebral injury and dysfunction of consciousness after cerebric surgery, etc. It contributes to recover the extremities function
of patientes with hemiplegia after stroke, and has a positive effect on promoting recovery and revival of brain function.

Pharmaceutical Intermediate CAS 33818-15-4 USP Standar API Citicoline Sodium Powder for Nootropic Drugs


Function:

1. It can reduce the resistance of blood vessel of brain and accelerate substance metabolism of brain.

2. It also can activate the mechanism of reticular formation of brain stem.

3. It can be used in the therapy of acute craniocerebral trauma and disturbance of consciousness after brain operation.


 

Pharmaceutical Intermediate CAS 33818-15-4 USP Standar API Citicoline Sodium Powder for Nootropic Drugs

Pharmaceutical Intermediate CAS 33818-15-4 USP Standar API Citicoline Sodium Powder for Nootropic Drugs

Pharmaceutical Intermediate CAS 33818-15-4 USP Standar API Citicoline Sodium Powder for Nootropic Drugs
Pharmaceutical Intermediate CAS 33818-15-4 USP Standar API Citicoline Sodium Powder for Nootropic Drugs
Pharmaceutical Intermediate CAS 33818-15-4 USP Standar API Citicoline Sodium Powder for Nootropic Drugs
Pharmaceutical Intermediate CAS 33818-15-4 USP Standar API Citicoline Sodium Powder for Nootropic Drugs
Pharmaceutical Intermediate CAS 33818-15-4 USP Standar API Citicoline Sodium Powder for Nootropic Drugs